|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/59 | (2006.01) |
| A61K 38/24 | (2006.01) |
| (11) | Number of the document | 2486051 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10763000.6 |
| Date of filing the European patent application | 2010-10-04 | |
| (97) | Date of publication of the European application | 2012-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation | 2020-07-10 |
| (86) | Number | PCT/GB2010/001854 |
| Date | 2010-10-04 |
| (87) | Number | WO 2011/042688 |
| Date | 2011-04-14 |
| (30) | Number | Date | Country code |
| 09252360 | 2009-10-05 | EP |
| (72) |
COTTINGHAM, Ian, CH
PLAKSIN, Daniel, CH
WHITE, Richard, Boyd, US
|
| (73) |
Ferring B.V.,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinis preparatas, apimantis rekombinantinį hCG |
| PHARMACEUTICAL PREPARATION COMPRISING RECOMBINANT hCG |
| Payment date | Validity (years) | Amount | |
| 2024-09-23 | 15 | 289.00 EUR |
| 2025-10-04 |